Genetic risk of atherosclerotic renal artery disease: The candidate gene approach in a renal angiography cohort

Hypertension

Volumn 44, Issue 4, 2004, Pages 448-453

  Van Onna, Marieke ^a   Kroon, Abraham A ^a   Houben, Alphons J H M ^a   Koster, Derk ^a   Zeegers, Maurice P A ^b,c   Henskens, Léon H G ^a   Plat, Arian W ^b   Stoffers, Henri E J H ^b   De Leeuw, Peter W ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Case control studies; Hypertension, renovascular; Nitric oxide synthase; Polymorphism; Renal artery; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ASPARTIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; METHIONINE; NITRIC OXIDE; THREONINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

AGED; ANGIOTENSINOGEN; ARTERIOSCLEROSIS; FEMALE; GENOTYPE; HUMANS; HYPERTENSION, RENOVASCULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTORS, ANGIOTENSIN; RETINAL ARTERY OCCLUSION; RISK FACTORS;

EID: 4644260363     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000141440.02210.da     Document Type: Article

References (33)

1. McLaughlin K, Jardine AG, Moss JG. ABC of arterial and venous disease. Renal artery stenosis. BMJ. 2000;320:1124-1127.
2. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 2000;20:484-492.
3. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15:1579-1592.
4. Spiering W, Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension. 2000;36:411-416.
5. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidai P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien, F. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994;344:910-913.
6. Hopkins PN, Hunt SC, Jeunemaitre X, Smith B, Solorio D, Fisher NDL, Hollenberg NK, Williams GH. Angiotensinogen Genotype Affects Renal and Adrenal Responses to Angiotensin II in Essential Hypertension. Circulation. 2002;105:1921-1927.
7. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, Smits P. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens. 2002;20:2023-2027.
8. Losito A, Parente B, Cao PG, Jeffery S, Afzal AR. ACE gene polymorphism and survival in atherosclerotic renovascular disease. Am J Kidney Dis. 2000;35:211-215.
9. Missouris CG, Barley J, Jeffery S, Carter ND, Singer DR, MacGregor GA. Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int. 1996;49:534-537.
10. Olivieri O, Grazioli S, Pizzolo F, Stranieri C, Trabetti E, Beltrame F, Girelli D, Pignatti PF, Corrocher R. Different impact of deletion polymorphism of gene on the risk of renal and coronary artery disease. J Hypertens. 2002;20:37-43.
11. Olivieri O, Trabetti E, Grazioli S, Stranieri C, Friso S, Girelli D, Russo C, Pignatti PF, Mansueto G, Corrocher R. Genetic polymorphisms of the renin-angiotensin system and atheromatous renal artery stenosis. Hypertension. 1999;34:1097-1100.
12. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
13. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RC, Strandness DE Jr. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866-2872.
14. Henskens LH, Spiering W, Stoffers HE, Soomers FL, Vlietinck RF, de Leeuw PW, Kroon AA. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocrates study. J Hypertens. 2003;21:81-86.
15. Sham P. Statistics in human genetics. Arnolds Applications of Statistics. London: Arnold; 1998.
16. Confounding and interaction in regression. In: Muller KE, eds. Applied Regression Analysis and Other Multivariable Methods, 2nd ed. Boston: PWS-KENT Publishing Company; 1988:163-180.
17. Berglund G, Andersson O, Wilhelmsen L. Prevalence of primary and secondary hypertension: studies in a random population sample. BMJ. 1976;2:554-556.
18. Sigurdsson JA, Bengtsson C, Tibblin E, Wojciechowski J. Prevalence of secondary hypertension in a population sample of Swedish women. Eur Heart J. 1983;4:424-433.
19. Lewin A, Blaufox MD, Castle H, Entwisle G, Langford H. Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med. 1985;145:424-427.
20. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch Intern Med. 1987;147:820-829.
21. Hollis S. A graphical sensitivity analysis for clinical trials with non-ignorable missing binary outcome. Stat Med. 2002;21:3823-3834.
22. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;361:598-604.
23. Tiret L, Cambien F. Departure from Hardy-Weinberg equilibrium should be systematically tested in studies of association between genetic markers and disease. Circulation. 1995;92:3364-3365.
24. Karvonen J, Kauma H, Kervinen K, Rantala M, Ikaheimo M, Paivansalo M, Savolainen MJ, Kesaniemi YA. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med. 2002;251:102-110.
25. Jachymova M, Horky K, Bultas J, Kozich V, Jindra A, Peleska J, Martasek P. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun. 2001;284:426-430.
26. Markus HS, Ruigrok Y, Ali N, Powell JF. Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke. 1998;29:1908-1911.
27. Meyrier A, Dratwa M, Sennesael J, Lachaud-Pettiti V. Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure. Am J Hypertens. 1998;11:1087-1092.
28. Jeerooburkhan N, Jones LC, Bujac S, Cooper JA, Miller GJ, Vallance P, Humphries SE, Hingorani AD. Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension. 2001;38:1054-1061.
29. Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S, Rossi G, Clerico A, Biagini A. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart. 2002;87:525-528.
30. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999;100:1515-1520.
31. Paolo Rossi G, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol. 2003;41:930-937.
32. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C, Trimarco B. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke. 2001:32:735-740.
33. Deng HW, Chen WM, Recker RR. Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics. 2001;157:885-897.